Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy.

The hepatitis B virus (HBV) is the prototype member of the Hepadnaviridae, an ancient family of hepatotropic DNA viruses, which may have originated from 360 to 430 million years ago and with evidence of endogenization in reptilian genomes >200 million years ago. The virus is currently estimated to infect more than 250 million humans. The extremely successful spread of this pathogen among the human population is explained by its multiple particulate forms, effective transmission strategies (particularly perinatal transmission), long induction period and low associated mortality. These characteristics confer selective advantages, enabling the virus to persist in small, disperse populations and spread worldwide, with high prevalence rates in many countries. The HBV replication strategy is remarkably complex and includes a multiplicity of particulate structures. In addition to the common virions containing DNA in a relaxed circular (rcDNA) or double-stranded linear (dslDNA) forms, the viral population includes virion-like particles containing RNA or "empty" (viral envelopes and capsids without genomes), subviral particles (only an envelope) and even naked capsids. Consequently, several forms of the genome coexist in a single infection: (i) the "traveler" forms found in serum, including rcDNA and dslDNA, which originate from retrotranscription of a messenger RNA (the pregenomic RNA, another form of the viral genome itself) and (ii) forms confined to the host cell nucleus, including covalently closed circular DNA (cccDNA), which leads to a minichromosome form associated with histones and viral proteins, and double-stranded DNA integrated into the host genome. This complex composition lends HBV a kind of "multiple personality". Are these additional particles and genomic forms simple intermediaries/artifacts or do they play a role in the viral life cycle?

[1]  S. Kaneko,et al.  Molecular functions and biological roles of hepatitis B virus x protein , 2006, Cancer science.

[2]  N. Xia,et al.  Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. , 2016, Journal of hepatology.

[3]  S. Litwin,et al.  INAUGURAL ARTICLES: Hepatocyte turnover during resolution of a transient hepadnaviral infection , 2003 .

[4]  F. Liu,et al.  Characterization of Full-Length Genomes of Hepatitis B Virus Quasispecies in Sera of Patients at Different Phases of Infection , 2015, Journal of Clinical Microbiology.

[5]  S. Urban,et al.  HBV DNA Integration: Molecular Mechanisms and Clinical Implications , 2017, Viruses.

[6]  J. Brosius,et al.  The genome of a Mesozoic paleovirus reveals the evolution of hepatitis B viruses , 2013, Nature Communications.

[7]  M. Ciccozzi,et al.  Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter? , 2014, World journal of gastroenterology.

[8]  M. Imamura,et al.  Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients , 2013, Journal of Gastroenterology.

[9]  S. Litwin,et al.  Detection of Clonally Expanded Hepatocytes in Chimpanzees with Chronic Hepatitis B Virus Infection , 2008, Journal of Virology.

[10]  M. Feitelson,et al.  The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease , 2014, Expert opinion on therapeutic targets.

[11]  B. Larke,et al.  Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey , 2011, Journal of viral hepatitis.

[12]  S. Jang,et al.  Effect of frameshift mutation in the pre-C region of hepatitis B virus on the X and C genes. , 1994, The Journal of general virology.

[13]  A. Kramvis The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics , 2016, Reviews in medical virology.

[14]  S. Litwin,et al.  Mechanism for CCC DNA Synthesis in Hepadnaviruses , 2009, PloS one.

[15]  Linda Miller Van Blerkom Role of viruses in human evolution. , 2003 .

[16]  M. Buti,et al.  Clinical Application of Estimating Hepatitis B Virus Quasispecies Complexity by Massive Sequencing: Correlation between Natural Evolution and On-Treatment Evolution , 2014, PloS one.

[17]  M. Chen,et al.  Role of B cells in antigen presentation of the hepatitis B core. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Delaney,et al.  Capsid Phosphorylation State and Hepadnavirus Virion Secretion , 2017, Journal of Virology.

[19]  Tokiko Watanabe,et al.  Involvement of host cellular multivesicular body functions in hepatitis B virus budding , 2007, Proceedings of the National Academy of Sciences.

[20]  Lue-Yen Tucker,et al.  Causes of death in patients with hepatitis B: A natural history cohort study in the United States , 2013, Hepatology.

[21]  C. Seeger,et al.  Distribution of Hepatitis B Virus Nuclear DNA , 2017, Journal of Virology.

[22]  R. Prange,et al.  Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT‐independent manner , 2010, Cellular microbiology.

[23]  J. Schmidt,et al.  Dynamics of hepatitis B virus infection in vivo. , 1997, Journal of hepatology.

[24]  J. Summers,et al.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells , 1986, Cell.

[25]  P. Simmonds Reconstructing the origins of human hepatitis viruses. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[26]  M. Feitelson,et al.  X antigen polypeptides in the sera of hepatitis B virus-infected patients. , 1990, Virology.

[27]  N. Terrault,et al.  AASLD guidelines for treatment of chronic hepatitis B , 2016, Hepatology.

[28]  Reinhild Prange Host factors involved in hepatitis B virus maturation, assembly, and egress , 2012, Medical Microbiology and Immunology.

[29]  E. Holmes,et al.  Endogenous Hepadnaviruses in the Genome of the Budgerigar (Melopsittacus undulatus) and the Evolution of Avian Hepadnaviruses , 2012, Journal of Virology.

[30]  M. Kann,et al.  Intracellular transport of hepatitis B virus. , 2007, World journal of gastroenterology.

[31]  Y. N. Park,et al.  Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. , 2005, Journal of hepatology.

[32]  Lai Wei,et al.  Serum HBV core‐related antigen is a good predictor for spontaneous HBeAg seroconversion in chronic hepatitis B patients , 2017, Journal of medical virology.

[33]  Sung Gyoo Park,et al.  Fidelity of hepatitis B virus polymerase. , 2003, European journal of biochemistry.

[34]  J. Summers,et al.  In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. , 1990, Virology.

[35]  R. Mace,et al.  Reproductive trade-offs in extant hunter-gatherers suggest adaptive mechanism for the Neolithic expansion , 2016, Proceedings of the National Academy of Sciences.

[36]  N. Haigwood,et al.  Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques , 2017, Nature Communications.

[37]  M. Feitelson,et al.  X antigen/antibody markers in hepadnavirus infections. Presence and significance of hepadnavirus X gene product(s) in serum. , 1990, Gastroenterology.

[38]  C. Feschotte,et al.  Genomic Fossils Calibrate the Long-Term Evolution of Hepadnaviruses , 2010, PLoS biology.

[39]  Angela M. Liu,et al.  Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma , 2012, Nature Genetics.

[40]  M. Tschapka,et al.  Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes , 2013, Proceedings of the National Academy of Sciences.

[41]  P. Roques,et al.  Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from mauritius island , 2013, Hepatology.

[42]  S. Günther,et al.  Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease , 1996, Journal of virology.

[43]  J. Summers,et al.  Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  N. Kootstra,et al.  Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues. , 2016, The Journal of infectious diseases.

[45]  R. Batey,et al.  Changing prevalence of hepatitis B virus in urbanized Australian Aborigines , 1993, Journal of gastroenterology and hepatology.

[46]  J. Hurley,et al.  Membrane budding and scission by the ESCRT machinery: it's all in the neck , 2010, Nature Reviews Molecular Cell Biology.

[47]  R. Green,et al.  Early Mesozoic Coexistence of Amniotes and Hepadnaviridae , 2014, PLoS genetics.

[48]  Jyun-Yuan Huang,et al.  The Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion , 2015, PLoS pathogens.

[49]  S. Staprans,et al.  Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA , 1991, Journal of virology.

[50]  M. Kann,et al.  Lipid-Mediated Introduction of Hepatitis B Virus Capsids into Nonsusceptible Cells Allows Highly Efficient Replication and Facilitates the Study of Early Infection Events , 2006, Journal of Virology.

[51]  E. Salas,et al.  The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection , 2017, PloS one.

[52]  H. Alter,et al.  A "NEW" ANTIGEN IN LEUKEMIA SERA. , 1965, JAMA.

[53]  Junn-Liang Chang,et al.  Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. , 2006, Biochemical and biophysical research communications.

[54]  Y. Shaul,et al.  Clathrin-mediated Endocytosis and Lysosomal Cleavage of Hepatitis B Virus Capsid-like Core Particles* , 2006, Journal of Biological Chemistry.

[55]  S. Yagi,et al.  Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core‐related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment , 2003, Journal of viral hepatitis.

[56]  R. Campos,et al.  Influence of overlapping genes on the evolution of human hepatitis B virus. , 2013, Virology.

[57]  Yanbao Yu,et al.  Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication. , 2016, Cell reports.

[58]  J. Summers,et al.  Integration of Hepadnavirus DNA in Infected Liver: Evidence for a Linear Precursor , 1999, Journal of Virology.

[59]  S. Ho,et al.  Dating the origin and dispersal of hepatitis B virus infection in humans and primates , 2013, Hepatology.

[60]  L. Kaderali,et al.  Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses , 2017, Cell host & microbe.

[61]  B. Cowie,et al.  Hepatitis B virus epidemiology. , 2015, Cold Spring Harbor perspectives in medicine.

[62]  A. Roseman,et al.  A structural model for maturation of the hepatitis B virus core. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Dandri,et al.  The Role of cccDNA in HBV Maintenance , 2017, Viruses.

[64]  T. Berg,et al.  Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors , 2015, Hepatology.

[65]  W. Gerlich,et al.  Large surface proteins of hepatitis B virus containing the pre-s sequence , 1984, Journal of virology.

[66]  Hyunwook Lee,et al.  Secretion of Genome-Free Hepatitis B Virus – Single Strand Blocking Model for Virion Morphogenesis of Para-retrovirus , 2011, PLoS pathogens.

[67]  S. Fletcher,et al.  Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor , 2016, Nature.

[68]  G. Leroux-Roels,et al.  The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate. , 2005, The Journal of general virology.

[69]  T. Volz,et al.  Serum HBV pgRNA as a clinical marker for cccDNA activity. , 2017, Journal of hepatology.

[70]  S. Ho,et al.  Dating the origin of hepatitis B virus reveals higher substitution rate and adaptation on the branch leading to F/H genotypes. , 2015, Molecular phylogenetics and evolution.

[71]  H. O'brodovich,et al.  Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.

[72]  K. Kitrinos,et al.  Genome‐free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy , 2015, Journal of viral hepatitis.

[73]  S. Urban,et al.  Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycans , 2007 .

[74]  Lai Wei,et al.  Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV , 2015, Gut.

[75]  N. M. Araujo,et al.  Hepatitis B virus infection from an evolutionary point of view: how viral, host, and environmental factors shape genotypes and subgenotypes. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[76]  A. Zlotnick,et al.  Full-Length Hepatitis B Virus Core Protein Packages Viral and Heterologous RNA with Similarly High Levels of Cooperativity , 2010, Journal of Virology.

[77]  K. Kvell,et al.  Comprehensive regression analysis of hepatitis B virus × antigen level and anti-HBx antibody titer in the sera of patients with HBV infection , 2008, Pathology & Oncology Research.

[78]  M. Imamura,et al.  Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine , 2007, Hepatology.

[79]  E. Tsochatzis,et al.  Global Epidemiology of Hepatitis B Virus (HBV) Infection , 2015, Current Hepatology Reports.

[80]  Xiangmei Chen,et al.  HBV RNA virion-like particles produced under nucleos(t)ide analogues treatment are mainly replication-deficient. , 2017, Journal of hepatology.

[81]  A. Lohse,et al.  Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo , 2017, Gut.

[82]  M. Manns,et al.  Structural organization of the hepatitis B virus minichromosome. , 2001, Journal of molecular biology.

[83]  Xuan Wang,et al.  Asymmetric partitioning of transfected DNA during mammalian cell division , 2016, Proceedings of the National Academy of Sciences.

[84]  E. Hildt,et al.  Subviral Hepatitis B Virus Filaments, like Infectious Viral Particles, Are Released via Multivesicular Bodies , 2015, Journal of Virology.

[85]  M. Kann,et al.  Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation , 2010, Cellular microbiology.

[86]  E. Holmes,et al.  Detection of Hepatitis B Virus Infection in Wild-Born Chimpanzees (Pan troglodytes verus): Phylogenetic Relationships with Human and Other Primate Genotypes , 2000, Journal of Virology.

[87]  E. Hildt,et al.  Isolation and molecular characterization of hepatitis B virus X‐protein from a baculovirus expression system , 1997, Hepatology.

[88]  B. McMahon,et al.  Hepatitis B‐associated polyarteritis nodosa in alaskan eskimos: Clinical and epidemiologic features and long‐term follow‐up , 1989, Hepatology.

[89]  S. Yagi,et al.  Hepatitis B Virus DNA-negative Dane Particles Lack Core Protein but Contain a 22-kDa Precore Protein without C-terminal Arginine-rich Domain* , 2005, Journal of Biological Chemistry.

[90]  V. Bruss Hepatitis B virus morphogenesis. , 2007, World journal of gastroenterology.

[91]  M. Bouchard,et al.  The Enigmatic X Gene of Hepatitis B Virus , 2004, Journal of Virology.

[92]  Sun Park,et al.  Phosphoacceptors Threonine 162 and Serines 170 and 178 within the Carboxyl-Terminal RRRS/T Motif of the Hepatitis B Virus Core Protein Make Multiple Contributions to Hepatitis B Virus Replication , 2014, Journal of Virology.

[93]  C. Espiritu,et al.  Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants , 2017, Antimicrobial Agents and Chemotherapy.

[94]  A. Zuckerman,et al.  Taxonomic classification of human hepatitis B virus. , 1986, Intervirology.

[95]  R. Bartenschlager,et al.  A Slow Maturation Process Renders Hepatitis B Virus Infectious. , 2016, Cell host & microbe.

[96]  Z. Tian,et al.  Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction , 2016, Cellular & Molecular Immunology.

[97]  S. Kanner,et al.  RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg , 2017, Science Translational Medicine.

[98]  A. Kramvis Genotypes and Genetic Variability of Hepatitis B Virus , 2014, Intervirology.

[99]  T. Umemura,et al.  Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy , 2006, Journal of Gastroenterology.

[100]  M. Levrero,et al.  Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function , 2009, Proceedings of the National Academy of Sciences.

[101]  S. Locarnini,et al.  Origins and Evolution of Hepatitis B Virus and Hepatitis D Virus. , 2016, Cold Spring Harbor perspectives in medicine.

[102]  P. Revill,et al.  Overview of hepatitis B viral replication and genetic variability. , 2016, Journal of hepatology.

[103]  Fabien Zoulim,et al.  Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. , 2011, Journal of hepatology.

[104]  C. Coffin,et al.  Hepatitis B virus lymphotropism: emerging details and challenges , 2018, Biotechnology & genetic engineering reviews.

[105]  M. Nassal Hepatitis B viruses: reverse transcription a different way. , 2008, Virus research.

[106]  M. Feitelson Products of the “x” gene in hepatitis B and related viruses , 1986, Hepatology.

[107]  D. Glebe,et al.  Role of glycosaminoglycans for binding and infection of hepatitis B virus , 2007, Cellular microbiology.

[108]  J. Verhoef,et al.  Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9 , 2011, Archives of Virology.

[109]  P. Su,et al.  HBV maintains electrostatic homeostasis by modulating negative charges from phosphoserine and encapsidated nucleic acids , 2016, Scientific Reports.

[110]  J. Tavis,et al.  Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis , 1996, Journal of virology.

[111]  R. Repp,et al.  Absence of free core antigen in anti-HBc negative viremic hepatitis B carriers. , 1992, Archives of virology. Supplementum.

[112]  K. Walters,et al.  Half-Life of the Duck Hepatitis B Virus Covalently Closed Circular DNA Pool In Vivo following Inhibition of Viral Replication , 2002, Journal of Virology.

[113]  Jianming Hu,et al.  Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application , 2017, Viruses.

[114]  K. Chayama,et al.  On-Treatment Low Serum HBV RNA Level Predicts Initial Virological Response in Chronic Hepatitis B Patients Receiving Nucleoside Analogue Therapy , 2015, Antiviral therapy.

[115]  J. Wands,et al.  Posttranscriptional regulation of hepatitis B virus replication by the precore protein , 1997, Journal of virology.

[116]  J. Summers,et al.  Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination , 1995, Journal of virology.

[117]  Junji Furuse,et al.  The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. , 2010, The oncologist.